This inventor holds 4 USPTO granted patents and 2 published patent applications and 4 EPO patents. Top assignee: Sanofi. Active years: 2017-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2019
Title: Christoph Pöverlein: Innovator in Pharmaceutical Compounds
Introduction
Christoph Pöverlein is a notable inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating various metabolic disorders. With a total of four patents to his name, Pöverlein's work is focused on innovative solutions for diabetes, obesity, and related conditions.
Latest Patents
Pöverlein's latest patents include groundbreaking research on azetidine compounds and isoindolinone compounds. The azetidine compounds serve as GPR119 modulators, which are useful for the prevention and treatment of diabetes, obesity, dyslipidemia, and related disorders. Furthermore, these compounds are recognized for their potential as active ingredients in pharmaceuticals and pharmaceutical compositions. Similarly, the isoindolinone compounds also act as GPR119 modulators, providing therapeutic benefits for the same range of metabolic disorders. This research highlights Pöverlein's commitment to advancing medical science and improving patient outcomes.
Career Highlights
Throughout his career, Christoph Pöverlein has been associated with Sanofi, a leading global healthcare company. His work at Sanofi has allowed him to collaborate with other experts in the field and contribute to the development of innovative pharmaceutical solutions. His dedication to research and development has positioned him as a key figure in the pharmaceutical industry.
Collaborations
Pöverlein has worked alongside notable colleagues such as Lothar Schwink and Christian Buning. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their shared field of expertise.
Conclusion
Christoph Pöverlein's contributions to pharmaceutical innovations, particularly in the area of metabolic disorder treatments, underscore his role as a leading inventor. His patents reflect a commitment to improving health outcomes through scientific research and collaboration.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile